Evidence map›Paper›PMID 41366847›Full record

ArticleJournal of the American Chemical Society2025

Unplugging Asymmetric Synthesis with a Wireless, Self-Pumping Electrochemical Reactor.

Sara Grecchi, Gerardo Salinas, Malinee Niamlaem, Alexander Kuhn, Serena Arnaboldi

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Tunable stereoselectivity in a wireless electrochemical microreactor using natural chiral ionic liquids.Green chemistry : an international journal and green chemistry resource : GC · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara GrecchiDipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milan, Italy.
Gerardo SalinasCNRS, Bordeaux INP, ISM, Univ. Bordeaux, UMR 5255, 33607 Pessac, France.ORCID 0000-0001-7621-7351
Malinee NiamlaemDipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milan, Italy.
Alexander KuhnCNRS, Bordeaux INP, ISM, Univ. Bordeaux, UMR 5255, 33607 Pessac, France.ORCID 0000-0002-1962-4863
Serena ArnaboldiDipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milan, Italy.ORCID 0000-0002-1981-4659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we report the first miniaturized, wireless electrochemical flow reactor capable of performing both reactant pumping and asymmetric synthesis within a single, integrated device. The reactor consists of a hollow, conductive polymer tube where the outer polypyrrole (Ppy) shell acts as an electromechanical pump, and the inner layer, constituted of a chiral thiophene-based oligomer, serves as the enantioselective catalyst. This integrated design overcomes mass-transport limitations and eliminates the need for external pumps. By employing an alternating current (AC) protocol, we achieve near-quantitative yield (99%) and exceptional enantioselectivity (>99% ee) for the reduction of acetophenone. The system's utility is showcased across three mechanistically distinct transformations, ketone reduction, sulfide oxidation, and reductive amination, culminating in the direct asymmetric synthesis of Ugi's amine, the chiral probe used in our mechanistic studies, with high stereocontrol (>99.5% ee). This work introduces a new paradigm for reagent-free, pump-free asymmetric synthesis and provides a validated, predictive model for the rational design of smart, automated chemical manufacturing platforms.

Identifiers

PMID41366847
PMCPMC12752701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.